Opdivo nivolumab: Updated Phase I/II data

Updated data from a cohort of 78 patients with metastatic urothelial cancer in the open-label, international Phase I/II CheckMate -032 trial showed

Read the full 229 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE